No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study
| Image |  |
|---|---|
| Description | scientific article published on 26 September 2018 |
| Author/s |
author: Giacomo Lus Alice Laroni Luca Prosperini |
| Publication date | September 26, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |